Exocrine Pancreatic Insufficiency Market Analysis

1
  Global Exocrine Pancreatic Insufficiency Market

2
Synopsis
The report provides market analysis, information
and insights into Global Exocrine Pancreatic
Insufficiency Market Exocrine pancreatic
insufficiency (EPI) is an inability of proper
digestion of food owing to insufficient levels of
digestive enzymes from pancreas. EPI is commonly
found in humans affected with Shwachman-Diamond
Syndrome and cystic fibrosis. EPI is triggered
by the progressive loss of pancreatic cells,
which generates the digestive enzymes. EPI
disturbs the normal growth, life expectancy and
immune response. Diarrhoea, Steatorrhea, fatigue
and weight loss are the key symptoms of
EPI. View more details _at_ http//www.bigmarketrese
arch.com/exocrine-pancreatic-insufficiency-market

3
Key Factors For Market Growth
  Key factors responsible for growth of this
market involve, increasing global incidences of
exocrine pancreatic insufficiency, demands of
advanced therapeutics and presence of significant
number of pipeline drugs. Recent trends in
therapeutics include lipase treatment in
dietetic patients, optimizing the chymotrypsin
and trypsin levels. However, in the painful
chronic exocrine pancreatitis, high dose protease
are estimated to be beneficial. Individual
pancreatic replacement therapy along with
pancreatin medication is advised to the patient
in severe cases. According to the research
conducted by Robbins basic pathology, exocrine
pancreatic insufficiency was observed to occur in
the 85 to 90 of patients with cystic fibrosis
in 2013. Pancreatic replacement therapy in EPI is
an extensively accepted mode of treatment and
aids in minimizing the malabsorption and related
malnutrition.
4
Market Considering Geographic Location
  Geographically, North America and Europe will
lead the market owing to high percentage of
geriatric population, significant number of
research and drug development activities.
However, Asia-Pacific region is expected to
show rapid growth owing to growth of
pharmaceutical and healthcare industry and
improving purchasing power of the service
providers in this region. Rapidly emerging
economies in region such as India, China, and
more disease prevalence will drive the growth of
exocrine pancreatic insufficiency market. Some of
the key players operated in the exocrine
pancreatic insufficiency market are Axcan,
Aptalis Pharma, Inc., Eli Lilly Co., Cilian AG,
Nordmark Arzneimittel GmbH Co. KG and
Laboratoires Mayoly Spindler.  
5
KEY BENEFITS

• The analysis helps in understanding the
  strategies adopted by various companies for
  gaining market share in Exocrine Pancreatic
  Insufficiency Market
• The report provides a comprehensive analysis of
  factors that drive and restrict the growth of the
  Exocrine Pancreatic Insufficiency Market
• The report provides the quantitative analysis of
  the current market and estimations through
  2014-2021 that assists in identifying the
  prevailing market opportunities to capitalize on
• Detailed study of the strategies of key leaders,
  partnerships and acquisitions in the Exocrine
  Pancreatic Insufficiency market would be
  informative for professionals in the corporate
  sector
• Porters Five Forces analysis examines the
  competitive structure of the global transdermal
  drug delivery systems market and would assist
  market strategists in making decisions.

6
KEY BENEFITS

• Pin-point analysis of geographic segments helps
  to identify opportunities for growth within the
  Exocrine Pancreatic Insufficiency Market
• Identification of key investment pockets for
  Exocrine Pancreatic Insufficiency market provide
  strategic assistance to decision makers
• An analysis for the market potential/
  attractiveness has been included for various
  product segments, therapeutics, devices and
  geographic regions along with a detailed analysis
  of factors responsible for the rapid growth of
  the market segments

7
KEY MARKET SEGMENTS
Exocrine Pancreatic Insufficiency market is
segmented by the mode of disease management,
diagnostic tests and geography.   MARKET BY
DISEASE MANAGEMENT   Nutritional
management Pancreatic enzyme replacement therapy
(PERT) Life style modifications approach   MARKET
BY DIAGNOSIS   Magnetic resonance imaging
(MRI) CT scanning Endoscopic ultra-sonography
(EUS) Blood tests Other tests  
8
Summary
  Get Global Exocrine Pancreatic Insufficiency
Market (Mode of Disease management, Type of
diagnostic tests and Geography) - Size, Share,
Global Trends, Company Profiles, Demand,
Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2014 -
2021 market research report Published by Allied
Market Research. The Report is available at
4515 for Single User Enquire About Report _at_
http//www.bigmarketresearch.com/report-enquiry/17
8784
9
Contact Us
Big Market Research Deep Joshi 5933 NE Win
Sivers Drive, 205, Portland, OR 97220 United
States Direct 1-503-894-6022 Toll Free
1-800-910-6452 Fax [phone] Email
help_at_bigmarketresearch.com Web
http//www.bigmarketresearch.com